drugset / Trial / NCT03793322

The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma

NCT03793322

Phase 1 Unknown 100 enrolled Zhujiang Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of liver tumors. By correlating the ICG fluorescence patterns with pathologically confirmed tumors , it would be possible to use fluorescence navigation system in helping promoting oncology treatment.

Timeline

Start
2017-01-01
Primary completion
2020-01-01
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Intravenous